心塞通口服液治疗急性心肌梗塞疗效观察

Effect of the XINSAITONG oral administration liquid cure the Acute myocardial infarction

目的:探讨心塞痛口服液治疗急性心肌梗塞的临床疗效。方法:将75例入选病人随机分为治疗组(A组)45例,对照组(B组)30例。两组病人均给予尿激酶溶栓,A组口服心塞痛口服液,B组口服西药阿司匹林,疗程均为2周。分别观察其血流变,QRS记分,以及梗死面积变化。结果:A组血流变,QRS记分,以及梗死面积变化的改善均明显优于B组(P<0.05或P<0.01)。结论:心塞痛口服液对于急性心肌梗塞具有较好的治疗作用。

Objective To observe the clinical curative effect of the XINSAITONG oral administration liquid to the acute myocardial infarction patients. Methods ： The 75 acute myocardial infarction patients randomly devlded into two groupe,the curative groupe（A groupe）45patients, and the control groupe（B groupe）30 patients. Two groupe patients treatment thrombolytic by intravenous drip urokinase, A groupe patients treatment by oral administration the XINSAITONG oral administration liquid, B groupe patients treatment by oral administration aspirin, the course of treatment is two weeks. Observe the change of the level of blood rheology, the record points of QRS wave of the electrocardiogram, and the square of myocardial infarction. Results ： The change of the level of blood rheclogy, the record points of QRS wave of the electrocardiogram, and the square of myocardial infarction, of A groupe compared with B groupe, the difference is significance. （ P 〈 0.05 or P 〈 0.01 ）. Conclusions ： The XINSAITONG oral administration liquid can effect the the acute myocardial infarction.